79 related articles for article (PubMed ID: 4824215)
21. Immobilized hydroxysteroid dehydrogenases for the transformation of steroids in water--organic solvent systems.
Carrea G; Colombi F; Mazzola G; Cremonesi P; Antonini E
Biotechnol Bioeng; 1979 Jan; 21(1):39-48. PubMed ID: 427261
[TBL] [Abstract][Full Text] [Related]
22. Thermodynamic analysis of remote substrate binding energy in 3α-hydroxysteroid dehydrogenase/carbonyl reductase catalysis.
Hwang CC; Chang PR; Hsieh CL; Chou YH; Wang TP
Chem Biol Interact; 2019 Apr; 302():183-189. PubMed ID: 30794798
[TBL] [Abstract][Full Text] [Related]
23. Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenases.
Finken MJ; Andrews RC; Andrew R; Walker BR
J Clin Endocrinol Metab; 1999 Sep; 84(9):3316-21. PubMed ID: 10487705
[TBL] [Abstract][Full Text] [Related]
24. Inactivation of corticosteroids in intestinal mucosa by 11 beta-hydroxysteroid: NADP oxidoreductase (EC 1.1.1.146).
Burton AF; Anderson FH
Am J Gastroenterol; 1983 Oct; 78(10):627-31. PubMed ID: 6578677
[TBL] [Abstract][Full Text] [Related]
25. Regulation of 11 beta-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action.
Hammami MM; Siiteri PK
J Clin Endocrinol Metab; 1991 Aug; 73(2):326-34. PubMed ID: 1856264
[TBL] [Abstract][Full Text] [Related]
26. Apparent cortisone reductase deficiency: a functional defect in 11beta-hydroxysteroid dehydrogenase type 1.
Jamieson A; Wallace AM; Andrew R; Nunez BS; Walker BR; Fraser R; White PC; Connell JM
J Clin Endocrinol Metab; 1999 Oct; 84(10):3570-4. PubMed ID: 10522997
[TBL] [Abstract][Full Text] [Related]
27. Relationships between the 3 - and 20 -hydroxysteroid. NAD-oxidoreductase activity of a crystalline-enzyme preparation.
Gibb W; Jeffery J
Eur J Biochem; 1971 Nov; 23(2):336-42. PubMed ID: 4333366
[No Abstract] [Full Text] [Related]
28. Studies on the active centre for the 3-hydroxy steroid-nicotinamide-adenine dinucleotide oxidoreductase activity of cortisone reductase.
Gibb W; Jeffery J
Biochem J; 1972 Jul; 128(4):136P-137P. PubMed ID: 4344695
[No Abstract] [Full Text] [Related]
29. Structural requirements for binding to the sugar-transport system of the human erythrocyte.
Barnett JE; Holman GD; Munday KA
Biochem J; 1973 Feb; 131(2):211-21. PubMed ID: 4722437
[TBL] [Abstract][Full Text] [Related]
30. Structure of the G225P/G226P mutant of mouse 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) ternary complex: implications for the binding of inhibitor and substrate.
Dhagat U; Endo S; Mamiya H; Hara A; El-Kabbani O
Acta Crystallogr D Biol Crystallogr; 2009 Mar; 65(Pt 3):257-65. PubMed ID: 19237748
[TBL] [Abstract][Full Text] [Related]
31. Reduction of the non-steroid adamantanone by crystalline preparations of cortisone reductase.
Gibb W; Jeffery J
Biochem J; 1972 Jan; 126(2):443. PubMed ID: 5071180
[No Abstract] [Full Text] [Related]
32. Influence of an 18-hydroxyl group on the interaction of oestrogens and hydroxysteroid oxidoreductases.
Findlay JK; Breuer H
Biochem J; 1974 Feb; 137(2):273-9. PubMed ID: 4824210
[TBL] [Abstract][Full Text] [Related]
33. [The effect of cofactors on the binding of steroid substrates with extrophilic hydroxysteroid dehydrogenase in the rabbit liver].
Smirnov AN
Biull Eksp Biol Med; 1990 Mar; 109(3):250-2. PubMed ID: 2364149
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of an affinity chromatography column designed for recovery of labile proteins.
Sweet F; Adair NK
Biochem Biophys Res Commun; 1975 Mar; 63(1):99-105. PubMed ID: 164861
[No Abstract] [Full Text] [Related]
35. Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure.
Cooper MS; Rabbitt EH; Goddard PE; Bartlett WA; Hewison M; Stewart PM
J Bone Miner Res; 2002 Jun; 17(6):979-86. PubMed ID: 12054173
[TBL] [Abstract][Full Text] [Related]
36. Mouse 17alpha-hydroxysteroid dehydrogenase (AKR1C21) binds steroids differently from other aldo-keto reductases: identification and characterization of amino acid residues critical for substrate binding.
Faucher F; Cantin L; Pereira de Jésus-Tran K; Lemieux M; Luu-The V; Labrie F; Breton R
J Mol Biol; 2007 Jun; 369(2):525-40. PubMed ID: 17442338
[TBL] [Abstract][Full Text] [Related]
37. Crystal structures of human Delta4-3-ketosteroid 5beta-reductase (AKR1D1) reveal the presence of an alternative binding site responsible for substrate inhibition.
Faucher F; Cantin L; Luu-The V; Labrie F; Breton R
Biochemistry; 2008 Dec; 47(51):13537-46. PubMed ID: 19075558
[TBL] [Abstract][Full Text] [Related]
38. Studies on a Tyr residue critical for the binding of coenzyme and substrate in mouse 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21): structure of the Y224D mutant enzyme.
Dhagat U; Endo S; Mamiya H; Hara A; El-Kabbani O
Acta Crystallogr D Biol Crystallogr; 2010 Feb; 66(Pt 2):198-204. PubMed ID: 20124700
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
Draper N; Walker EA; Bujalska IJ; Tomlinson JW; Chalder SM; Arlt W; Lavery GG; Bedendo O; Ray DW; Laing I; Malunowicz E; White PC; Hewison M; Mason PJ; Connell JM; Shackleton CH; Stewart PM
Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176
[TBL] [Abstract][Full Text] [Related]
40. Characterization of 11beta-hydroxysteroid dehydrogenase activities in the renal cell line LLC-PK1: evidence for a third isoform?
Möbus E; Hermans JJ; Maser E
Endocrine; 1999 Dec; 11(3):301-7. PubMed ID: 10786827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
